Jessup Wealth Management Inc Invests $2.11 Million in CME Group Inc. (NASDAQ:CME)

Jessup Wealth Management Inc acquired a new stake in CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 7,933 shares of the financial services provider's stock, valued at approximately $2,105,000. CME Group makes up about 0.9% of Jessup Wealth Management Inc's portfolio, making the stock its 26th largest position.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. SeaCrest Wealth Management LLC raised its holdings in CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider's stock worth $366,000 after purchasing an additional 40 shares in the last quarter. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after acquiring an additional 43 shares during the last quarter. Wealthcare Advisory Partners LLC boosted its holdings in shares of CME Group by 3.6% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 1,342 shares of the financial services provider's stock valued at $356,000 after purchasing an additional 47 shares during the last quarter. Koshinski Asset Management Inc. increased its stake in CME Group by 1.4% during the 1st quarter. Koshinski Asset Management Inc. now owns 3,522 shares of the financial services provider's stock worth $934,000 after buying an additional 48 shares during the period. Finally, Berry Wealth Group LP increased its stake in CME Group by 0.4% during the 1st quarter. Berry Wealth Group LP now owns 13,561 shares of the financial services provider's stock worth $3,598,000 after buying an additional 49 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Stock Performance

Shares of NASDAQ CME traded down $0.45 during trading hours on Thursday, hitting $275.19. 1,602,078 shares of the stock were exchanged, compared to its average volume of 2,195,961. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a market capitalization of $99.17 billion, a P/E ratio of 27.69, a P/E/G ratio of 3.74 and a beta of 0.44. The company's 50 day moving average is $276.73 and its 200 day moving average is $258.73. CME Group Inc. has a one year low of $193.17 and a one year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The business's quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the business posted $2.50 EPS. On average, research analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date was Monday, June 9th. CME Group's payout ratio is 50.30%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Morgan Stanley boosted their price objective on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Barclays upped their price target on shares of CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a research note on Thursday. Keefe, Bruyette & Woods boosted their target price on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a report on Thursday, April 24th. JPMorgan Chase & Co. cut their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a report on Thursday, April 24th. Finally, Bank of America upped their price objective on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research note on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $260.93.

Insider Activity at CME Group

In related news, Director Larry G. Gerdes sold 2,000 shares of CME Group stock in a transaction dated Thursday, April 24th. The shares were sold at an average price of $264.10, for a total transaction of $528,200.00. Following the completion of the transaction, the director directly owned 38,651 shares of the company's stock, valued at $10,207,729.10. This trade represents a 4.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Derek Sammann sold 4,650 shares of CME Group stock in a transaction dated Monday, May 5th. The shares were sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the transaction, the insider directly owned 8,336 shares of the company's stock, valued at $2,339,164.96. This represents a 35.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock worth $3,680,610 in the last ninety days. Company insiders own 0.30% of the company's stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.